story of the week
Efficacy and Safety of Treatment With Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis: The OLYMPIA 1 Randomized Clinical Phase 3 Trial
JAMA Dermatol 2024 Nov 27;[EPub Ahead of Print], S Ständer, G Yosipovitch, FJ Legat, A Reich, C Paul, D Simon, L Naldi, M Metz, A Tsianakas, A Pink, S Fage, G Micali, E Weisshaar, H Sundaram, A Metelitsa, M Augustin, A Wollenberg, B Homey, MC Fargnoli, H Sofen, NJ Korman, L Skov, X Chen, ZK Jabbar-Lopez, C Piketty, SG KwatraFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.